SEC Company Response from TELA Bio, (TELA) — Dec 28, 2020
TELA Bio, Inc.
Date: Dec. 28, 2020 · CIK: 0001561921 · Accession: 0001104659-20-139371
AI Filing Summary & Sentiment
File numbers found in text: 333-251505
Letter
TELA Bio, Inc.
1 Great Valley Parkway, Suite 24
Malvern, Pennsylvania 19355
December 28, 2020
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Manufacturing
100 F Street NE
Washington, D.C. 20549
Re:
TELA Bio, Inc.
Registration Statement on Form S-3
SEC File No. 333-251505
Filed December 18, 2020
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, TELA Bio, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-251505) (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:00 PM, eastern time, on December 29, 2020, or as soon thereafter as is practicable.
Please feel free to direct any questions or comments concerning this request to Rachael Bushey, Esq. of Troutman Pepper Hamilton Sanders LLP at (215) 981-4331.
TELA BIO, Inc.
By: /s/ Antony Koblish
Name: Antony Koblish
Title: President and Chief Executive Officer
Cc: Rachael Bushey, Troutman Pepper Hamilton Sanders LLP
Show Raw Text
CORRESP
1
filename1.htm
TELA
Bio, Inc.
1 Great Valley Parkway, Suite 24
Malvern, Pennsylvania 19355
December 28, 2020
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Manufacturing
100 F Street NE
Washington, D.C. 20549
Re:
TELA Bio, Inc.
Registration Statement on Form S-3
SEC File No. 333-251505
Filed December 18, 2020
Ladies and Gentlemen:
Pursuant to Rule 461
under the Securities Act of 1933, as amended, TELA Bio, Inc. (the “Company”) hereby requests that the effective
date of the Company’s Registration Statement on Form S-3 (File No. 333-251505) (the “Registration Statement”)
be accelerated so that the Company’s Registration Statement will become effective at 4:00 PM, eastern time, on December 29,
2020, or as soon thereafter as is practicable.
Please feel free to direct
any questions or comments concerning this request to Rachael Bushey, Esq. of Troutman Pepper Hamilton Sanders LLP at (215) 981-4331.
TELA BIO, Inc.
By:
/s/ Antony Koblish
Name: Antony Koblish
Title: President and Chief Executive Officer
Cc: Rachael Bushey, Troutman Pepper Hamilton Sanders LLP